Clinical Scorecard: PFAS Exposure Linked to Faster Epigenetic Aging

At a Glance

Key Highlights

• PFNA and PFSA detected in ~95% of participants
• Strongest associations found in men and adults aged 50-64
• PFNA linked to accelerated epigenetic aging via GrimAge metrics
• Legacy PFAS like PFOA and PFOS not significantly associated
• Need for further research on cumulative health risks of PFAS mixtures

Guideline-Based Recommendations

Diagnosis

• Assess PFAS exposure through serum concentration measurements

Management

• Consider lifestyle factors like smoking when evaluating risks

Monitoring & Follow-up

• Utilize multiple epigenetic aging algorithms for comprehensive assessment

Risks

• Increased risk of accelerated aging in men and older adults

Patient & Prescribing Data

Adults aged 50 years and older

Focus on reducing exposure to PFNA and PFSA

Clinical Best Practices

• Incorporate environmental exposure assessments in aging studies
• Advocate for policies to limit exposure to harmful PFAS compounds

References

• Study on PFAS and epigenetic aging